Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide.
about
Targeting autophagy to sensitive glioma to temozolomide treatmentIDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells.Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expressionChromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas.Overexpression of TELO2 decreases survival in human high-grade gliomas.An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas.Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like PropertiesVolatile Oil of Acori Graminei Rhizoma-Induced Apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells.β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.The potential of combi-molecules with DNA-damaging function as anticancer agents.RLIP76 Depletion Enhances Autophagic Flux in U251 Cells.In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme.MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomasTumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeMicroRNA in Glioblastoma: An Overview.Characterization of Byproducts from Chemical Syntheses of Oligonucleotides Containing 1-Methyladenine and 3-Methylcytosine.Glycosylation Changes in Brain Cancer.Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy.Small-Molecule Kinase-Inhibitors-Loaded Boron Cluster as Hybrid Agents for Glioma-Cell-Targeting Therapy.Analysis of Histone Deacetylase-Dependent Effects on Cell Migration Using the Stripe Assay.Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.New insights into long noncoding RNAs and their roles in glioma.Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.A novel polysaccharide derived from algae extract inhibits cancer progression via JNK, not via the p38 MAPK signaling pathway.Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide.LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.Potential Strategies Overcoming the Temozolomide Resistance for GlioblastomaRe-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvageGlioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive MicroenvironmentBlockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
P2860
Q28066270-23743F8A-A825-4722-B401-6DA4D56E7066Q33709922-0FB4B503-2F0E-4730-B8C7-5579797624C3Q35973580-049FC90A-A942-4977-B86A-E10C72A39876Q37144157-6A408532-73A9-4010-AEB2-43E5D71C70BCQ37541852-BFF414D9-A841-4B66-B8A9-D55932B7E208Q37564650-EE6DD958-F7C0-4401-89CC-9D7F049AADDEQ37670401-62A7DE02-7559-4B74-8F2B-4E3A2CCBC672Q37691110-4F695567-8101-4BD1-B787-92A5CE5A4486Q38557755-F1248A93-A53B-485F-9A4A-4C029BDF2606Q38641444-E014AD18-FE6E-4BA2-A809-5B7BD4C6423CQ38694505-25994220-9A0A-4BF7-9C30-955CC7349269Q38713528-85BF5A0D-9EC2-440E-B123-933381979478Q38754819-4E5C71EB-FC53-4B32-9283-A5CCC9271B8AQ38769884-91C7332E-782D-4CD5-97FE-337D373ED69FQ38787480-4E788FFB-4C73-41E5-95D2-F5F600C8860EQ41612669-64164CC5-C47F-4053-937B-3998763F4ADFQ41686929-06700872-9BD7-462A-A356-A6A6DE579977Q42577813-FB203617-8468-4C6D-AE8C-2F8DDF0D4567Q47142132-D478AEE0-5BE0-4CE2-BA68-1EDC8D582DF7Q47160383-758353E1-6F27-4008-A760-7772F776DE45Q47691736-9477D980-5EFE-4DC5-B573-EDFC7C043EDEQ47706727-EC3AEB88-8A5A-4A4A-9ACF-BF6222815FCAQ48292219-8E00A1A0-168B-45CC-A0F3-72E48C36C0C7Q48470174-4A6CBAD2-D6B1-4B0E-8F01-ECEF8BF62E9FQ48487663-0D1B86D6-474B-4783-B3C4-B3926A701CA3Q49843574-7D794BC7-FB20-4161-BD8F-BD0E0C90E964Q50089383-47C6BB44-4C7E-4CBD-9C45-F042B12E3040Q50420563-218E4A7F-64A3-4FB0-91E8-87F4AE2E7BB1Q52562611-0239D7D1-94F1-4E08-B5CA-809506777F18Q52644558-1AE93B23-C65B-4D10-BD3E-6ED69FC2BAEAQ53750643-CB6B87D0-F647-47DA-8CDC-BC7CACD08E93Q55327757-DFAFCC6B-FC5D-4FDB-87AD-D34B987925AAQ55510465-432AFDF1-8B53-4DF1-826E-A343BD286C8BQ57153312-12893FF1-C538-48D4-A54C-0A655E5D6477Q58130556-94F06BF1-CE6D-49AB-95AB-4ABF54747B4BQ58785727-5DAE2C1C-9071-4D1F-8C0B-ADAC9288E2B8Q59129078-6FF144B7-D6AA-4EDA-9027-B173BC7EAFD2
P2860
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Toward an effective strategy i ...... glioblastoma to temozolomide.
@en
type
label
Toward an effective strategy i ...... glioblastoma to temozolomide.
@en
prefLabel
Toward an effective strategy i ...... glioblastoma to temozolomide.
@en
P1433
P1476
Toward an effective strategy i ...... f glioblastoma to temozolomide
@en
P2093
Anne Clavreul
Khaled Messaoudi
P304
P356
10.1016/J.DRUDIS.2015.02.011
P577
2015-03-02T00:00:00Z